317 related articles for article (PubMed ID: 18806522)
21. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials.
Okrainec K; Platt R; Pilote L; Eisenberg MJ
J Am Coll Cardiol; 2005 Jan; 45(2):177-84. PubMed ID: 15653013
[TBL] [Abstract][Full Text] [Related]
22. Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.
Aronow WS
Expert Opin Pharmacother; 2016; 17(2):205-15. PubMed ID: 26373919
[TBL] [Abstract][Full Text] [Related]
23. [High blood pressure and coronary heart disease. Are there new therapeutic options?].
Motz W
Herz; 2004 May; 29(3):255-65. PubMed ID: 15167951
[TBL] [Abstract][Full Text] [Related]
24. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
; ; ; Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pearson T; Pfeffer MA; Taubert KA
J Am Coll Cardiol; 2006 May; 47(10):2130-9. PubMed ID: 16697342
[No Abstract] [Full Text] [Related]
25. Use of reperfusion therapy and cardiovascular drugs in the treatment of 146 men and 54 women with ST-segment elevation myocardial infarction at a University Medical Center.
Sukhija R; Aronow WS; Nayak D; McClung JA; Monsen CE; Belkin RN
Am J Ther; 2005; 12(3):277-80. PubMed ID: 15891275
[TBL] [Abstract][Full Text] [Related]
26. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
Rockx MA; Haddad H
Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
28. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
[TBL] [Abstract][Full Text] [Related]
29. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
Etminan M; Zhang B; Fitzgerald M; Brophy JM
Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
[TBL] [Abstract][Full Text] [Related]
30. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
31. A managed care organization's use of integrated health management to improve secondary prevention of coronary artery disease.
Berthiaume JT; Davis J; Taira DA; Thein KK
Am J Manag Care; 2007 Mar; 13(3):142-7. PubMed ID: 17335357
[TBL] [Abstract][Full Text] [Related]
32. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.
Brener SJ; Ivanc TB; Poliszczuk R; Chen M; Tuzcu EM; Hu T; Frid DJ; Nissen SE
Am Heart J; 2006 Dec; 152(6):1059-63. PubMed ID: 17161053
[TBL] [Abstract][Full Text] [Related]
34. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
35. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy.
Makowsky MJ; McAlister FA; Galbraith PD; Southern DA; Ghali WA; Knudtson ML; Tsuyuki RT;
Am Heart J; 2008 Feb; 155(2):348-55. PubMed ID: 18215607
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
[TBL] [Abstract][Full Text] [Related]
37. Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial.
Marcantoni C; Zanoli L; Rastelli S; Tripepi G; Matalone M; Di Landro D; Scandura S; Tamburino C; Zoccali C; Castellino P
J Nephrol; 2009; 22(1):13-6. PubMed ID: 19229814
[TBL] [Abstract][Full Text] [Related]
38. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
[TBL] [Abstract][Full Text] [Related]
39. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
40. Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study.
Tuttolomondo A; Di Raimondo D; Di Sciacca R; Pedone C; La Placa S; Arnao V; Pinto A; Licata G
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):642-9. PubMed ID: 22502765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
